Beta2-microglobulin is a better predictor of treatment-free survival in patients with chronic lymphocytic leukaemia if adjusted according to glomerular filtration rate.

J Delgado, G Pratt, N Phillips, J Briones, C Fegan, J Nomdedeu, C Pepper, A Aventin, R Ayats, S Brunet, R Martino, D Valcarcel, D Milligan, J. Sierra

Research output: Contribution to journalArticleResearch

36 Citations (Scopus)
Original languageEnglish
Pages (from-to)801-805
JournalBr J Haematol
Issue number6
Publication statusPublished - 1 Jun 2009

Cite this